BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of September 18, 2026, BDRX stock price declined to $0.73 with 458,193 million shares trading.

BDRX has a beta of 2.31, meaning it tends to be more sensitive to market movements. BDRX has a correlation of 0.05 to the broad based SPY ETF.

BDRX has a market cap of $751,218.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, BDRX traded as high as $11,012.50 and as low as $.61.

BDRX has underperformed the market in the last year with a price return of -97.8% while the SPY ETF gained +16.8%. BDRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -76.1% and -13.9%, respectively, while the SPY returned +2.3% and -0.9%, respectively.

BDRX support price is $.70 and resistance is $.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.